CARR vs RCUS · P/E 43, rev $21.75B vs rev $258.0M
Carrier Global Corp (CARR) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the CARR and RCUS stock pages for the full models.
Not investment advice.